EUVIMEDEUVIMED entdecken
Crossref

Endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine ameliorates lipopolysaccharide-induced airway inflammation and bronchial hyperreactivity in mice

Yasemin Karaman iD, Yesim Kaya-Yasar, Sevgen Celik Onder, Turgut Emrah Bozkurt, Inci Sahin-Erdemli

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgaf112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Yasemin Karaman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye-Ankara, Turkey. Hauptthemen laut MEDLINE: Arginine, Bronchial Hyperreactivity, Nitric Oxide Synthase, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Hacettepe University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor. ADMA concentrations are augmented in lung, plasma samples of asthmatics. It remains unclear whether the increased concentration of ADMA in airway inflammation contributes to the pathophysiology or acts as a protective mechanism. The objective of this study was to evaluate the effects of exogenous ADMA on airway inflammation in mice.

Methods

Ex vivo/in vivo airway inflammation models were used. Tracheal tissues, isolated from female Balb/c mice were incubated with lipopolysaccharide (LPS), ADMA, or LPS + ADMA for 4 days in tissue culture. Tracheal reactivity was evaluated afterward by agonist-induced contraction responses. Female Balb/c mice were applied i.n. LPS (0,1 mg/ml) to induce in vivo airway inflammation. ADMA (30 mg/kg) was administered by i.n. route 1 h before and 24 h after LPS application. Key findings I.n. ADMA application augmented lung ADMA levels, reduced nitrite levels in bronchoalveolar lavage (BAL) fluid, prevented bronchial hyperreactivity and airway inflammation. ADMA also prevented bronchial hyperreactivity when applied 15 min before methacholine nebulization during the assessment of airway function.

Conclusion

Exogenously applied ADMA may have protective effects in airway inflammation by limiting excessive nitric oxide (NO) production. Targeting the DDAH/ADMA/NOS pathway may provide a therapeutic approach for airway inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArginineBronchial HyperreactivityNitric Oxide SynthaseInflammationEnzyme InhibitorsAnimalsLipopolysaccharidesFemaleMice, Inbred BALB CMiceTracheaBronchoalveolar Lavage FluidLungNitric OxideDisease Models, AnimalAsthmaMethacholine Chloride

Stichwörter der Autor:innen

airway inflammationasymmetric dimethylargininebronchial hyperreactivitylipopolysaccharide

Substanzen

ArginineLipopolysaccharidesN,N-dimethylarginineNitric Oxide SynthaseNitric OxideEnzyme InhibitorsMethacholine Chloride

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye-Ankara, Turkey.
  • Department of Pharmacology, Faculty of Pharmacy, Karadeniz Technical University, Üniversite Mah. 61080 Ortahisar-Trabzon, Turkey.
  • Department of Pathology, Faculty of Medicine, Hacettepe University, 06100 Sıhhiye-Ankara, Turkey.

ORCID-Profile: Yasemin Karaman

Förderung

  • Hacettepe University Scientific Research Projects Coordination Unit

Zitieren

APA

Karaman, Y., Kaya-Yasar, Y., Onder, S. C., Bozkurt, T. E., & Sahin-Erdemli, I. (2026). Endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine ameliorates lipopolysaccharide-induced airway inflammation and bronchial hyperreactivity in mice. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf112

Vancouver

Karaman Y, Kaya-Yasar Y, Onder SC, Bozkurt TE, Sahin-Erdemli I. Endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine ameliorates lipopolysaccharide-induced airway inflammation and bronchial hyperreactivity in mice. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgaf112

BibTeX
@article{Karaman2026,
  author = {Karaman, Yasemin and Kaya-Yasar, Yesim and Onder, Sevgen Celik and Bozkurt, Turgut Emrah and Sahin-Erdemli, Inci},
  title = {Endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine ameliorates lipopolysaccharide-induced airway inflammation and bronchial hyperreactivity in mice},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgaf112}
}
Kostenlos starten →